-
Sector Analysis
Pharmapoint: HER2-Positive Breast Cancer – Global Drug Forecast and Market Analysis to 2025
HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. Today, HER2-positive breast cancer patients are living longer with their disease, thanks to established disease management strategies using numerous combinations of chemotherapy with Herceptin, Perjeta, and the tyrosine kinase inhibitor (TKI) Tykerb (lapatinib). During the forecast period from 2015–2025, GlobalData expects that the HER2-positive market will grow due to the launch of HER2-targeted agents in the early disease setting and...
-
Product Insights
Duodenal Cancer Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Duodenal Cancer Global Clinical Trials Review, H1, 2019" provides an overview of Duodenal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Duodenal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Duodenal Cancer Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Duodenal Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Duodenal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Duodenal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Metastatic Breast Cancer Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Metastatic Breast Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Breast Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...